Latest News:
Subscribe to the latest in micro-cap news and podcasts, straight to your inbox.
Subscribe Now
Facebook Twitter Instagram Youtube

Featured News

Read More
About Hemp-Derived CBD
Cannabidiol (CBD) is one of at least 113 active cannabinoids identified in cannabis. It is a major phytocannabinoid, accounting for up to 40% of the plant’s extract.
Read More
Remedi – CBD Professionals you Can Trust
The team of Remedi is a collaboration project of hemp and CBD professionals.
Read More
Pressure BioSciences' New CBD Technology
Pressure Biosciences unveils new CBD beverage infusing technology
Watch Video

Hot Stocks of the Day

 
Hot Stocks of the Day by TradingView

Latest News

CytoDyn Shares Exciting Results from their Triple-Negative Breast Cancer Treatment Program with The Stock Day Podcast (CYDY) December 5, 2019.
Radio Interviews 

CytoDyn Shares Exciting Results from their Triple-Negative Breast Cancer Treatment Program with The Stock Day Podcast (CYDY) December 5, 2019.

Jesse Knittel Comments Off on CytoDyn Shares Exciting Results from their Triple-Negative Breast Cancer Treatment Program with The Stock Day Podcast (CYDY) December 5, 2019.

Newsfile Corp. Newsfile Corp Phoenix, Arizona–(Newsfile Corp. – December 5, 2019) – The Stock Day Podcast welcomed CytoDyn (OTCQB: CYDY)

WOW Unlimited Media’s Michael Hirsh Joins the Stock Day Podcast (WOWMF) December 5, 2019.
Radio Interviews 

WOW Unlimited Media’s Michael Hirsh Joins the Stock Day Podcast (WOWMF) December 5, 2019.

Jesse Knittel Comments Off on WOW Unlimited Media’s Michael Hirsh Joins the Stock Day Podcast (WOWMF) December 5, 2019.
American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)
BioTech 

American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)

Jesse Knittel Comments Off on American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)
Supreme Cannabis Expands CPG Manufacturing Capacity and Provides Operational Update
Cannabis 

Supreme Cannabis Expands CPG Manufacturing Capacity and Provides Operational Update

Jesse Knittel Comments Off on Supreme Cannabis Expands CPG Manufacturing Capacity and Provides Operational Update

Cannabis

Supreme Cannabis Expands CPG Manufacturing Capacity and Provides Operational Update
Cannabis 

Supreme Cannabis Expands CPG Manufacturing Capacity and Provides Operational Update

Jesse Knittel Comments Off on Supreme Cannabis Expands CPG Manufacturing Capacity and Provides Operational Update

Supreme Cannabis expands its manufacturing capacity with a 107,000 square foot central processing facility in Kitchener, Ontario. Blissco Facility to

Dixie Brands’ Wholly-Owned Subsidiary Secures Patent for Scientific Breakthrough in Cannabinoid Delivery
Cannabis 

Dixie Brands’ Wholly-Owned Subsidiary Secures Patent for Scientific Breakthrough in Cannabinoid Delivery

Jesse Knittel Comments Off on Dixie Brands’ Wholly-Owned Subsidiary Secures Patent for Scientific Breakthrough in Cannabinoid Delivery
Global Canna Labs successfully exports Medical Cannabis from Jamaica to Canada
Cannabis 

Global Canna Labs successfully exports Medical Cannabis from Jamaica to Canada

Jesse Knittel Comments Off on Global Canna Labs successfully exports Medical Cannabis from Jamaica to Canada
Harvest One Signs Supply Agreement with the Alberta Gaming, Liquor & Cannabis Commission
Cannabis 

Harvest One Signs Supply Agreement with the Alberta Gaming, Liquor & Cannabis Commission

Jesse Knittel Comments Off on Harvest One Signs Supply Agreement with the Alberta Gaming, Liquor & Cannabis Commission

Energy

IsoEnergy Finalizes Uranium Target Areas for Winter Drilling; Notes Increasing Uranium Price in Spot Market
Energy 

IsoEnergy Finalizes Uranium Target Areas for Winter Drilling; Notes Increasing Uranium Price in Spot Market

Jesse Knittel Comments Off on IsoEnergy Finalizes Uranium Target Areas for Winter Drilling; Notes Increasing Uranium Price in Spot Market

Aggressive Infill and Step-Out Program to Follow Up on High-Grade Uranium Discovery in Eastern Athabasca Basin; Spot U3O8 price has

UPDATE: NeoVolta Becomes First Lithium Iron Phosphate Energy Storage System Approved by California Energy Commission
Energy 

UPDATE: NeoVolta Becomes First Lithium Iron Phosphate Energy Storage System Approved by California Energy Commission

Jesse Knittel Comments Off on UPDATE: NeoVolta Becomes First Lithium Iron Phosphate Energy Storage System Approved by California Energy Commission
FuelCell Energy Inc. Announces New $200 Million Strategic Corporate Loan Facility with Orion Energy Partners
Energy 

FuelCell Energy Inc. Announces New $200 Million Strategic Corporate Loan Facility with Orion Energy Partners

Jesse Knittel Comments Off on FuelCell Energy Inc. Announces New $200 Million Strategic Corporate Loan Facility with Orion Energy Partners
US Nuclear Joins Fight Against Widespread Toxic PFAS Chemical Pollution in Our Air and Water
Energy 

US Nuclear Joins Fight Against Widespread Toxic PFAS Chemical Pollution in Our Air and Water

Jesse Knittel Comments Off on US Nuclear Joins Fight Against Widespread Toxic PFAS Chemical Pollution in Our Air and Water

Mining

Amex Drills 41.30 g/t Gold over 4.10 m including 202.81 g/t Au over 0.80 m in New Emerging Upper Gratien Zone, Perron Project
Mining 

Amex Drills 41.30 g/t Gold over 4.10 m including 202.81 g/t Au over 0.80 m in New Emerging Upper Gratien Zone, Perron Project

Jesse Knittel Comments Off on Amex Drills 41.30 g/t Gold over 4.10 m including 202.81 g/t Au over 0.80 m in New Emerging Upper Gratien Zone, Perron Project

Shallow intercept of up to 41.30 g/t Au over 4.1 m including 202.81 g/t Au over 0.8 m in Upper

Calibre Mining Announces a 318% Increase in the Pavon Gold Project Indicated Resource to 230,000 ounces Grading 5.16 g/t Gold; Resource Expansion Drilling Planned for 2020
Mining 

Calibre Mining Announces a 318% Increase in the Pavon Gold Project Indicated Resource to 230,000 ounces Grading 5.16 g/t Gold; Resource Expansion Drilling Planned for 2020

Jesse Knittel Comments Off on Calibre Mining Announces a 318% Increase in the Pavon Gold Project Indicated Resource to 230,000 ounces Grading 5.16 g/t Gold; Resource Expansion Drilling Planned for 2020
Anaconda Mining Discovers New Prospective Areas at its Tilt Cove Gold Project and Initiates Trenching and Drilling Program
Mining 

Anaconda Mining Discovers New Prospective Areas at its Tilt Cove Gold Project and Initiates Trenching and Drilling Program

Jesse Knittel Comments Off on Anaconda Mining Discovers New Prospective Areas at its Tilt Cove Gold Project and Initiates Trenching and Drilling Program
Nouveau Monde Provides an Update on Its Strategy to Produce Spherical Graphite Destined to Lithium-ion Batteries Market
Mining 

Nouveau Monde Provides an Update on Its Strategy to Produce Spherical Graphite Destined to Lithium-ion Batteries Market

Jesse Knittel Comments Off on Nouveau Monde Provides an Update on Its Strategy to Produce Spherical Graphite Destined to Lithium-ion Batteries Market

Biotech

American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)
BioTech 

American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)

Jesse Knittel Comments Off on American BriVision Initiates Phase II Part I Clinical Trial for ABV-1505 in Adult Attention-Deficit Hyperactivity Disorder (ADHD)

 PDC-1421, the active ingredient of ABV-1505, is being expanded into adult ADHD trials following encouraging Phase II trial results in

Algernon Pharmaceuticals’ NP-120 (Ifenprodil) Outperforms Merck’s Phase 3 Drug MK-7264 (Gefapixant) in an Acute Cough Study by 110%
BioTech 

Algernon Pharmaceuticals’ NP-120 (Ifenprodil) Outperforms Merck’s Phase 3 Drug MK-7264 (Gefapixant) in an Acute Cough Study by 110%

Jesse Knittel Comments Off on Algernon Pharmaceuticals’ NP-120 (Ifenprodil) Outperforms Merck’s Phase 3 Drug MK-7264 (Gefapixant) in an Acute Cough Study by 110%
Applied BioSciences Announces Strategic Shift to Fully Focus on BioPharma Division
BioTech 

Applied BioSciences Announces Strategic Shift to Fully Focus on BioPharma Division

Jesse Knittel Comments Off on Applied BioSciences Announces Strategic Shift to Fully Focus on BioPharma Division
BioCorRxs Subsidiary, BioCorRx Pharmaceuticals Provides Update on Potential Overdose Reversal Drug Candidate VDM-001
BioTech 

BioCorRxs Subsidiary, BioCorRx Pharmaceuticals Provides Update on Potential Overdose Reversal Drug Candidate VDM-001

Jesse Knittel Comments Off on BioCorRxs Subsidiary, BioCorRx Pharmaceuticals Provides Update on Potential Overdose Reversal Drug Candidate VDM-001